Journal Mobile Options
Table of Contents
Vol. 60, No. 4, 2012
Issue release date: June 2012

Documentation of Functional and Clinical Effects of Infant Nutrition: Setting the Scene for COMMENT

Koletzko B. · Szajewska H. · Ashwell M. · Shamir R. · Aggett P. · Baerlocher K. · Noakes P. · Braegger C. · Calder P. · Campoy Folgoso C. · Colomb V. · Decsi T. · Domellöf M. · Dupont C. · Fewtrell M. · van Goudoever J.B. · Michaelsen K.F. · Mihatsch W. · Guarino A. · Koletzko S. · Rigo J. · Turck D. · Taminiau J. · on behalf of the Early Nutrition Academy and European Society for Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition – Consensus Group on Outcome Measures Made in Paediatric Enteral Nutrition Clinical Trials
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

The Early Nutrition Academy and the Child Health Foundation, in collaboration with the Committee on Nutrition, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, held a workshop in March 2011 to explore guidance on acquiring evidence on the effects of nutritional interventions in infants and young children. The four objectives were to (1) provide guidance on the quality and quantity of evidence needed to justify conclusions on functional and clinical effects of nutrition in infants and young children aged <3 years; (2) agree on a range of outcome measures relevant to nutrition trials in this age group for which agreed criteria are needed; (3) agree on an updated ‘core data set’ that should generally be recorded in nutrition trials in infants and young children, and (4) provide guidance on the use of surrogate markers in paediatric nutrition research. The participants discussed these objectives and agreed to set up six first working groups under the auspices of the Consensus Group on Outcome Measures Made in Paediatric Enteral Nutrition Clinical Trials (COMMENT). Five groups will aim to identify and define criteria for assessing key outcomes, i.e. growth, acute diarrhoea, atopic dermatitis and cows’ milk protein allergy, infections and ‘gut comfort’. The sixth group will review and update the ‘core data set’. The COMMENT Steering Committee will discuss and decide upon a method for reaching consensus which will be used by all working groups and plan to meet again within 2 years and to report and publish their conclusions.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Koletzko B, Aggett PJ, Bindels JG, Bung P, Ferre P, Gil A, et al: Growth, development and differentiation: a functional food science approach. Br J Nutr 1998;80(suppl 1): S5–S45.
  2. Koletzko B, Decsi T, Molnar D, de la Hunty A (eds): Early Nutrition Programming and Health Outcomes in Later Life: Obesity and Beyond. Advances in Experimental Medicine and Biology. Springer, 2009, vol 646:1–196.

    External Resources

  3. Aggett PJ, Agostini C, Goulet O, Hernell O, Koletzko B, Lafeber HL, Michaelsen KF, Rigo J, Weaver LT; European Society of Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on Nutrition: The nutritional and safety assessment of breast milk substitutes and other dietary products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2001;32:256–258.
  4. Koletzko B, Ashwell M, Beck B, Bronner A, Mathioudakis B: Characterisation of infant food modifications in the European Union. Ann Nutr Metab 2002;46:231–242.
  5. Aggett P, Agostoni C, Axelsson I, Goulet O, Hernell O, Koletzko B, Lafeber HN, Michaelsen KF, Morley R, Rigo J, Szajewska H, Weaver LT; ESPGHAN Committee on Nutrition: Core data for nutrition trials in infants: a discussion document – a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2003;36:338–342.

    External Resources

  6. Scientific Committee on Food: Report of the Scientific Committee on Food on the Revision of Essential Requirements of Infant Formulae and Follow-on Formulae. Brussels, Scientific Committee on Food, 2003.
  7. Committee on the Evaluation of the Addition of Ingredients New to Infant Formula: Infant Formula: Evaluating the Safety of New Ingredients. Washington, National Academies Press, 2001.
  8. Aggett PJ, Agostoni C, Axelsson I, Edwards CA, Goulet O, Hernell O, Koletzko B, Lafeber HN, Micheli JL, Michaelsen KF, Rigo J, Szajewska H, Weaver LT; ESPGHAN Committee on Nutrition: Nondigestible carbohydrates in the diets of infants and young children: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2003;36:329–337.
  9. Braegger C, Chmielewska A, Decsi T, Kolacek S, Mihatsch W, Moreno L, Pieścik M, Puntis J, Shamir R, Szajewska H, Turck D, van Goudoever J; ESPGHAN Committee on Nutrition: Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr 2011;52:238–250.

    External Resources

  10. Johnston BC, Shamseer L, da Costa BR, Tsuyuki RT, Vohra S: Measurement issues in trials of pediatric acute diarrheal diseases: a systematic review. Pediatrics 2010;126:e222–e231.

    External Resources

  11. Brooks P, Boers M, Simon LS, Strand V, Tugwell P: Outcome measures in rheumatoid arthritis: the OMERACT process. Expert Rev Clin Immunol 2007;3:271–275.

    External Resources

  12. Tugwell P, Boers M, Brooks P, Simon L, Strand V, Idzerda L: OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials 2007;8:38.

    External Resources

  13. Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC: The ClinicalTrials.gov results database – update and key issues. N Engl J Med 2011;364:852–860.
  14. Bourgeois FT, Murthy S, Mandl KD: Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med 2010;153:158–166.
  15. Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332.
  16. AbuMweis SS, Jew S, Jones PJ: Optimizing clinical trial design for assessing the efficacy of functional foods. Nutr Rev 2010;68:485–499.

    External Resources

  17. Klein MA, Nahin RL, Messina MJ, Rader JI, Thompson LU, Badger TM, et al: Guidance from an NIH workshop on designing, implementing, and reporting clinical studies of soy interventions. J Nutr 2010;140:1192S–1204S.
  18. Shane AL, Cabana MD, Vidry S, Merenstein D, Hummelen R, Ellis CL, et al: Guide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants. Gut Microbes 2010;1:243–253.

    External Resources

  19. Welch RW, Antoine JM, Berta JL, Bub A, de Vries J, Guarner F, Hasselwander O, Hendriks H, Jäkel M, Koletzko BV, Patterson CC, Richelle M, Skarp M, Theis S, Vidry S, Woodside JV; International Life Sciences Institute Europe Functional Foods Task Force: Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods. Br J Nutr 2011;106(suppl 2):S3–S15.

    External Resources

  20. de Onis M, Siyam A, Borghi E, Onyango AW, Piwoz E, Garza C: Comparison of the World Health Organization growth velocity standards with existing US reference data. Pediatrics 2011;128:e18–e26.

    External Resources

  21. Megan B, Pickering RM, Weatherall M: Design, objectives, execution and reporting of published open-label extension studies. J Eval Clin Pract 2012;18:209–215.

    External Resources

  22. Fewtrell MS, Kennedy K, Singhal A, Martin RM, Ness A, Hadders-Algra M, et al: How much loss to follow-up is acceptable in long-term randomised trials and prospective studies? Arch Dis Child 2008;93:458–461.

    External Resources

  23. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R: Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008;121:e850–e856.
  24. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E: Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357:1076–1079.
  25. Georgiou NA, Garssen J, Witkamp RF: Pharma-nutrition interface: the gap is narrowing. Eur J Pharmacol 2010;651:1–8.

    External Resources

  26. Diplock A, Aggett P, Ashwell M, Bornet F, Fern E, Roberfroid M: Scientific concepts of functional foods in Europe: consensus document. Br J Nutr 1999;81:S1–S27.
  27. Aggett PJ, Antoine JM, Asp NG, Bellisle F, Contor L, Cummings JH, Howlett J, Müller DJ, Persin C, Pijls LT, Rechkemmer G, Tuijtelaars S, Verhagen H: PASSCLAIM: consensus on criteria. Eur J Nutr 2005;44(suppl 1):i5–i30.

    External Resources

  28. Fekete K, Marosvolgyi T, Jakobik V, Decsi T: Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review. Am J Clin Nutr 2009;89:2070S–2084S.
  29. Hooper L, Ashton K, Harvey LJ, Decsi T, Fairweather-Tait SJ: Assessing potential biomarkers of micronutrient status by using a systematic review methodology: methods. Am J Clin Nutr 2009;89:1953S–1959S.
  30. Lowe NM, Fekete K, Decsi T: Methods of assessment of zinc status in humans: a systematic review. Am J Clin Nutr 2009;89:2040S–2051S.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50